Cosmetic indications for botulinum A toxin

Seminars in Ophthalmology

Volumn 13, Issue 3, 1998, Pages 142-148

  Foster, Jill A ^a   Wulc, Allan E ^a   Holck, David E E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

AGING; DRUG EFFICACY; EYELID; FACE MUSCLE; FOREHEAD; HUMAN; INJECTION SITE; INTRAMUSCULAR DRUG ADMINISTRATION; MUSCLE CONTRACTION; MUSCLE RELAXATION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0031792020     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820539809066090     Document Type: Review

References (22)

1. Borodic GE, Cheney M, McKenna M. Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plast Reconstr Surg. 1992;90:972-979.
2. Pierard GE, Lapiere CM. The microanatomical basis of facial frown lines. Arch Dermatol. 1989;125:1090-1092.
3. Simpson LL. The origin structure, and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981;33:155-188.
4. Sloop RR, Escutin RO, Malus JA, et al. Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A. Neurology. 1996;46:1382-1386.
5. Sloop RR, Cole BA, Escutin RO. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use. Neurology. 1997;48:249-251.
6. Garcia A, Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin: A dose response study. Dermatol Surg. 1996;22:39-43.
7. Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg. 1993;119:1018-1022.
8. Guyurm B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994;93:913-918.
9. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17-21.
10. Foster JA, Wulc AE, Barnhorst D, et al. The use of botulinum A toxin to ameliorate facial dynamic lines. Int J Aesthetic Restor Surg. 1996;4:137-144.
11. Pribitkin EA, Greco TM, Goode RL, et al. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection. Arch Otolaryngol Head Neck Surg. 1997;123:321-326.
12. Foster JA, Barnhorst D, Papay FA, et al. The use of botulinum A toxin to treat frown lines. Ophthalmology. 1996;103: 618-622.
13. Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997;12:325-347.
14. Ellis PA, Tan AK. Cosmetic upper-facial rejuvenation with botulinum. J Otolaryngol. 1997;26:92-96.
15. Shaari CM, Sanders IS. Qualifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve. 1993;16:964-969.
16. Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord. 1994;9:31-39.
17. Elopra R, Tugnoli V, DeGrandis D. The variability in the clinical effect induced by botulinum toxin type A. The role of muscle activity in humans. Move Disord. 1997;12:89-94.
18. Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Move Disord. 1994;9:213-217.
19. Nussgens Z, Roggenkamper P. Long-term treatment of blepharospasm with botulinum toxin type. Ger J Ophthalmol. 1995;4:363-367.
20. Dutton JJ, Buckley EG. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology. 1988;95:1529-1534.
21. Foster JA, Barnhorst D, Papay F, et al. The use of botulinum A toxin to ameliorate facial kinetic frown lines. Presented at the American Society of Ophthalmic Plastic & Reconstructive Surgery, Chicago, IL, October 26, 1996.
22. Guyuron B, Huddleston SW. Aesthetic indications for botulinum toxin injection. Plast Reconstr Surg. 1994;93:913-918.